KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
Operating Margin for KemPharm (KMPH)
Operating Margin as of May 2024 (TTM): -400.65%
According to KemPharm's latest financial reports and stock price the company's current Operating Margin is -400.65%. At the end of 2021 the company had an Operating Margin of -29.74%.
Operating Margin history for KemPharm from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -29.74% | -69.11% |
| 2020 | -96.28% | -49.63% |
| 2019 | -191.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | -125.52% | -68.67% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | -6.99% | -98.26% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | -9.64% | -97.59% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -451.32% | 12.65% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.